Cholesterol’s Hidden Role in Alzheimer’s Brain Dynamics
Some brain regions are more vulnerable to Alzheimer’s disease than others. A new study suggests that this might be due to how they uptake cholesterol [1]. Why do some parts...
Some brain regions are more vulnerable to Alzheimer’s disease than others. A new study suggests that this might be due to how they uptake cholesterol [1]. Why do some parts...
ThirdLaw Molecular is developing a new class of therapeutic molecules with potential to address age-related deterioration. Five years ago, we … Continue reading "New spiroligomer molecules can ‘change medicine’" The...
Researchers have found a new avenue for approaching spinal disc degeneration and published their work in Aging Cell. A very common problem Back problems in […]
Landmark conference concludes with call for unified physical theory of aging and enhanced AI–biology integration. The inaugural Global Conference on … Continue reading "Gerophysics gathers momentum as new discipline in...
A recent study reported significant associations between increased heat days and accelerated epigenetic aging [1]. Heat alters DNA While warm summer days on […]
Company says senolytic therapeutic delivers ‘robust vision improvements’ in DME patients despite failing to meet primary endpoint. Longevity focused biotech … Continue reading "UNITY Biotech reveals topline results from senolytic...
Research highlights role of C15:0 in cellular resilience and slowing biological aging – positioning fatty15 as key supplement for longevity. … Continue reading "Longevity nutrient C15:0 aids cellular resilience and...
According to an open-label study from Washington University in St. Louis, the anti-amyloid drug gantenerumab reduced the risk of developing familial Alzheimer’s […]
According to an open-label study from Washington University in St. Louis, the anti-amyloid drug gantenerumab reduced the risk of developing familial Alzheimer’s disease in a subgroup of participants [1]. Is...
Startup boasts pipeline of candidates targeting neuromuscular, neurodegenerative and cardio-metabolic diseases. Belgian biotech Augustine Therapeutics has raised $84.8 million in … Continue reading "Augustine Therapeutics lands $85m to advance HDAC6...
CTA Content